What outpatient antibiotic regimen and duration are recommended for a superficial abdominal skin abscess caused by non‑tuberculous Mycobacterium that also requires MRSA coverage?

Treatment of Non-Tuberculous Mycobacterial Abdominal Skin Abscess with MRSA Coverage

For a superficial abdominal skin abscess caused by non-tuberculous mycobacterium requiring MRSA coverage, perform incision and drainage first, then initiate combination oral therapy with trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets twice daily PLUS moxifloxacin or sitafloxacin for at least 3-6 months, with treatment duration guided by clinical response and culture results.

Primary Management Approach

Surgical Intervention

Incision and drainage is the cornerstone of treatment for any cutaneous abscess 1. This is non-negotiable and must be performed before or concurrent with antibiotic therapy. The abscess cavity should be thoroughly debrided of any necrotic tissue or foreign material 2, 3.

Antibiotic Selection Strategy

For MRSA Coverage (Empiric Initial Treatment): While awaiting mycobacterial culture results, you must cover MRSA empirically given the purulent nature of the abscess. The IDSA guidelines provide clear options 1, 4:

• TMP-SMX: 1-2 double-strength tablets PO twice daily (A-II recommendation)
• Alternative: Doxycycline 100 mg PO twice daily (A-II recommendation)
• Alternative: Clindamycin 300-450 mg PO three times daily (A-II recommendation)

For Non-Tuberculous Mycobacterium (Once Identified): Based on recent case evidence, NTM skin infections respond to specific combinations 2, 3:

• TMP-SMX remains active against many NTM species including Mycolicibacterium neworleansense 2
• Fluoroquinolones (moxifloxacin or sitafloxacin) provide excellent NTM coverage 2, 3
• Aminoglycosides (amikacin) for severe or resistant cases 2, 3
• Imipenem shows activity but requires IV administration 2, 3

Recommended Outpatient Regimen

Start with dual oral therapy:

1. TMP-SMX 1-2 double-strength tablets PO twice daily (covers both MRSA and many NTM species)
2. PLUS Moxifloxacin 400 mg PO once daily (enhanced NTM coverage)

This combination addresses both pathogens while remaining feasible for outpatient management 2.

Treatment Duration

Duration: 3-6 months minimum 2, 3

The duration differs dramatically from typical MRSA skin infections (5-10 days) 1, 4. NTM infections require prolonged therapy:

• Continue treatment for at least 3 months after clinical resolution of all signs and symptoms 2, 3
• Most successful cases in the literature used 11-12 months total duration 3
• For superficial infections with complete surgical drainage, 3-6 months may suffice if clinical response is excellent 2

Monitor closely: If no improvement after 2-4 weeks, consider:

• Repeat surgical debridement
• Adding a third agent (clofazimine or tigecycline)
• Consultation with infectious disease specialist 3

Critical Caveats and Pitfalls

Diagnostic Considerations

• Obtain cultures before antibiotics from the abscess fluid for both routine bacterial culture AND mycobacterial culture with susceptibility testing 1
• Request 16S rRNA gene sequencing if NTM is suspected, as species identification guides therapy 2
• NTM typically takes 2-6 weeks to grow in culture, so empiric MRSA coverage must continue initially

When to Escalate Care

Hospitalization and IV therapy are indicated if 1:

• Signs of systemic illness (fever, tachycardia, hypotension)
• Rapidly progressive infection despite oral antibiotics
• Immunocompromised host (diabetes, HIV, immunosuppressive medications)
• Inability to completely drain the abscess
• Lack of clinical response after 48-72 hours of appropriate therapy

Macrolide Resistance Warning

Many NTM species, particularly M. abscessus, harbor inducible macrolide resistance via the erm(41) gene 3. Do not use azithromycin or clarithromycin as monotherapy or even in combination for skin/soft tissue NTM infections unless susceptibility is confirmed 5, 3.

Avoid These Common Errors

• Do NOT use rifampin for skin infections—it promotes resistance and lacks supporting data 1, 4
• Do NOT stop antibiotics at 7-10 days as you would for typical MRSA abscesses—NTM requires months 2, 3
• Do NOT rely on incision and drainage alone when NTM is confirmed—antibiotics are essential 2, 3

Adjustments Based on Culture Results

If MRSA confirmed but NTM negative:

• Narrow to MRSA-specific therapy
• Complete 5-10 days total 1, 4

If NTM confirmed (species-specific adjustments):

• M. abscessus: Consider adding clofazimine; may need IV amikacin + imipenem initially 3
• M. marinum: Doxycycline + rifampin or ethambutol
• M. fortuitum/chelonae: TMP-SMX + fluoroquinolone usually adequate
• Adjust based on susceptibility testing results 2